HomeCERO • NASDAQ
add
CERo Therapeutics Holdings Inc
Previous close
$0.43
Day range
$0.44 - $0.50
Year range
$0.40 - $102.00
Market cap
3.48M USD
Avg Volume
3.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.11M | 12.19% |
Net income | -5.11M | -122.03% |
Net profit margin | — | — |
Earnings per share | -1.59 | — |
EBITDA | -5.03M | -13.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.20M | 13.29% |
Total assets | 7.99M | -11.72% |
Total liabilities | 8.32M | -36.15% |
Total equity | -329.39K | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -179.84% | — |
Return on capital | -3,555.59% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.11M | -122.03% |
Cash from operations | -4.45M | 12.49% |
Cash from investing | — | — |
Cash from financing | 6.32M | -11.67% |
Net change in cash | 1.88M | -9.69% |
Free cash flow | -2.44M | -120.46% |
About
Founded
2020
Headquarters
Website
Employees
8
